Effect of sputum quality on Mycobacterium avium-intracellulare complex lung disease diagnosis and treatment initiation according to disease type
Authors:
- 23 July 2022
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 104 (3) , 115773
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Antimicrobial Activity of Neutrophils Against MycobacteriaFrontiers in Immunology, 2021
- Prevalence and Clinical Characteristics of Nontuberculous Mycobacteria in Patients with Bronchiectasis: A Systematic Review and Meta-AnalysisRespiration, 2021
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineClinical Infectious Diseases, 2020
- Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guidelineEuropean Respiratory Journal, 2020
- Ultrasensitive enzyme-linked immunosorbent assay for the detection of MPT64 secretory antigen to evaluate Mycobacterium tuberculosis viability in sputumInternational Journal of Infectious Diseases, 2020
- Natural history ofMycobacterium aviumcomplex lung disease in untreated patients with stable courseEuropean Respiratory Journal, 2017
- Nodular Bronchiectatic Mycobacterium avium Complex Pulmonary Disease. Natural Course on Serial Computed Tomographic ScansAnnals of the American Thoracic Society, 2013
- Clinical Significance of the Differentiation Between Mycobacterium avium and Mycobacterium intracellulare in M avium Complex Lung DiseaseChest, 2012
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007